Ryan Arthur F

Director

1 company

Insider Signal Score

Average

Trades Analyzed

12M Win Rate

37.8%

Avg 3M Return

-2.7%

Avg 12M Return

-2.1%

Ryan Arthur F serves as a Director at REGN. Across recent SEC filings that breaks down to 0 buys and 490 sells. Those positions are worth an estimated $11.2M at current prices.

Historically, Ryan Arthur F's trades have earned a middling insider score of 54/100 across 38 rated trades. Over a 12-month horizon, 37.8% of those trades were profitable, with an average 12-month return of -2.1%.

The biggest single holding is REGN (~$11.2M) as Director. The recent filings there lean toward selling, a net 14,196 shares.

Holdings by Company

REGNJul 2, 2026

Current Shares17.3K

Est. Value$11.25M

Net Activity-14,196

Bought: 0Sold: 14.2K

Transaction History

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 1, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$899.61	$89,960.51	-0.5%	+19.3%	-34.7%
Apr 1, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$962.53	$96,253.25	-0.5%	+9.0%	-36.3%
Mar 1, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	76	$980.50	$74,517.94	-0.4%	-1.3%	-28.9%
Feb 1, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$954.22	$95,422.26	-0.5%	-5.7%	-29.7%
Jan 2, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$899.90	$89,990.14	-0.5%	+7.1%	-21.0%
Dec 1, 2023	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	86	$815.43	$70,126.70	-0.5%	+18.6%	-7.9%
Nov 7, 2023	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$827.90	$82,789.98	-0.5%	+12.7%	-1.7%
Aug 1, 2023	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$736.59	$73,659.19	-0.5%	+5.2%	+46.0%
Jul 3, 2023	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$716.88	$71,687.70	-0.5%	+13.9%	+45.5%
Jun 1, 2023	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$735.42	$73,541.52	-0.5%	+14.2%	+34.1%